Literature DB >> 19395269

Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node.

Y Kimura1, Y Ariyoshi, M Shimahara, S Miyatake, S Kawabata, K Ono, M Suzuki, A Maruhashi.   

Abstract

We treated 6 patients with recurrent oral cancer and metastasis to the cervical lymph nodes after conventional treatments in 5 and non-conventional in 1 using BNCT, and herein report our results. The clinical response in our patients ranged from CR to PD. In 5 cases, spontaneous pain decreased immediately after BNCT. Three of the 6 are alive at the time of writing and we found that BNCT contributed to QOL improvement in all.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19395269     DOI： 10.1016/j.apradiso.2009.03.019

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN： 0969-8043            Impact factor:   1.513


  10 in total

1.  Electroporation optimizes the uptake of boron-10 by tumor for boron neutron capture therapy (BNCT) mediated by GB-10: a boron biodistribution study in the hamster cheek pouch oral cancer model.

Authors:  Marcela A Garabalino; Nahuel Olaiz; Agustina Portu; Gisela Saint Martin; Silvia I Thorp; Emiliano C C Pozzi; Paula Curotto; María E Itoiz; Andrea Monti Hughes; Lucas L Colombo; David W Nigg; Verónica A Trivillin; Guillermo Marshall; Amanda E Schwint
Journal:  Radiat Environ Biophys       Date:  2019-05-23       Impact factor: 1.925

Review 2.  Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era.

Authors:  Minoru Suzuki
Journal:  Int J Clin Oncol       Date:  2019-06-05       Impact factor: 3.402

3.  Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors.

Authors:  Weilian Yang; Rolf F Barth; Gong Wu; Tianyao Huo; Werner Tjarks; Michael Ciesielski; Robert A Fenstermaker; Brain D Ross; Carol J Wikstrand; Kent J Riley; Peter J Binns
Journal:  J Neurooncol       Date:  2009-07-09       Impact factor: 4.130

Review 4.  Boron delivery agents for neutron capture therapy of cancer.

Authors:  Rolf F Barth; Peng Mi; Weilian Yang
Journal:  Cancer Commun (Lond)       Date:  2018-06-19

5.  A realistic appraisal of boron neutron capture therapy as a cancer treatment modality.

Authors:  Rolf F Barth; Zizhu Zhang; Tong Liu
Journal:  Cancer Commun (Lond)       Date:  2018-06-19

Review 6.  Boron Neutron Capture Therapy: A Review of Clinical Applications.

Authors:  Timothy D Malouff; Danushka S Seneviratne; Daniel K Ebner; William C Stross; Mark R Waddle; Daniel M Trifiletti; Sunil Krishnan
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

Review 7.  The basis and advances in clinical application of boron neutron capture therapy.

Authors:  Huifang He; Jiyuan Li; Ping Jiang; Suqing Tian; Hao Wang; Ruitai Fan; Junqi Liu; Yuyan Yang; Zhibo Liu; Junjie Wang
Journal:  Radiat Oncol       Date:  2021-11-07       Impact factor: 3.481

8.  Homocystamide Conjugates of Human Serum Albumin as a Platform to Prepare Bimodal Multidrug Delivery Systems for Boron Neutron Capture Therapy.

Authors:  Tatyana Popova; Maya A Dymova; Ludmila S Koroleva; Olga D Zakharova; Vladimir A Lisitskiy; Valeria I Raskolupova; Tatiana Sycheva; Sergei Taskaev; Vladimir N Silnikov; Tatyana S Godovikova
Journal:  Molecules       Date:  2021-10-29       Impact factor: 4.411

Review 9.  Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer.

Authors:  Rolf F Barth; M Graca H Vicente; Otto K Harling; W S Kiger; Kent J Riley; Peter J Binns; Franz M Wagner; Minoru Suzuki; Teruhito Aihara; Itsuro Kato; Shinji Kawabata
Journal:  Radiat Oncol       Date:  2012-08-29       Impact factor: 3.481

10.  In Vivo Accelerator-Based Boron Neutron Capture Therapy for Spontaneous Tumors in Large Animals: Case Series.

Authors:  Vladimir Kanygin; Aleksandr Kichigin; Alexander Zaboronok; Anna Kasatova; Elena Petrova; Alphiya Tsygankova; Evgenii Zavjalov; Bryan J Mathis; Sergey Taskaev
Journal:  Biology (Basel)       Date:  2022-01-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.